M
$ Value
$364K
Shares
20,000
Price
$18
Filed
Nov 12
Insider
Name
Mazdyasni Matthew
Title
—
CIK
0001809915
Roles
Director
Transaction Details
Transaction Date
2025-11-10
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
34,763
Footnotes
Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. | These stock options were fully vested and exercisable.
Filing Info
Mazdyasni Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-10 | ASTH | M | $364K |
| 2025-11-10 | ASTH | M | $0 |
| 2025-06-11 | ASTH | A | $0 |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-14 |